查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1709451

流动止血钳市场，按产品类型、应用、最终用户、国家和地区 - 2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Flowable Hemostats Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年流动止血钳市场规模价值 7.5054 亿美元，2025 年至 2032 年的复合年增长率为 6.01%。

止血技术的进步，例如更快的应用和更好的生物相容性，正在提高其有效性。此外，微创手术的需求也促进了流动止血钳的使用。目前，北美和欧洲凭藉先进的医疗保健体系引领市场，而亚太地区正经历快速成长。挑战包括高成本和监管障碍。然而，不断增加的医疗保健投资和创新继续推动市场扩张。

流动止血钳市场-市场动态

全球范围内外科手术的增加增加了对止血解决方案的需求。

全球范围内外科手术数量的不断增加是推动流动止血钳市场发展的重要因素。 《柳叶刀》杂誌发表的一项研究估计，全球每年约进行 2.34 亿次大型外科手术。如此高的出血量凸显了对有效止血剂控製手术期间出血的迫切需求。

流动止血钳以其易于使用和有效控制出血而闻名，正在成为手术工具包中必不可少的工具。随着全球人口老化和慢性病盛行率上升，预计对外科手术的需求将会增加，进一步推动先进止血解决方案的需求。

流动止血钳市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 6.01%

根据产品类型细分，预计明胶止血剂将在 2024 年占据最大市场份额

根据应用细分，心血管手术是 2024 年的主要应用

根据最终用户细分，医院是 2024 年领先的最终用户

按地区划分，北美是 2024 年的主要收入来源

流动止血钳市场-細項分析：

全球流动止血钳市场根据产品类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为四类：明胶基止血剂、胶原基止血剂、组合止血剂和凝血酶基止血剂。明胶基止血剂因其多功能性、有效性以及在各种外科手术过程中控制出血的易用性而占据流动止血剂市场主导地位。这些止血剂透过快速吸收血液并形成机械屏障来促进凝血。它们在心血管、骨科和普通外科手术中的广泛应用推动了它们的市场领先地位。根据美国食品药物管理局（FDA）的说法，明胶止血剂是手术室中最常使用的止血剂之一。外科医生更喜欢它们，因为它们具有生物相容性、易于应用，并且对不规则伤口表面有效。此外，微创手术和创伤病例的不断增加进一步刺激了它们的需求。配方改进、吸收率加快等持续进步正在提高其性能，巩固其市场领先地位。

根据应用，市场分为两类：心血管外科、骨科手术、一般外科、神经外科、妇科手术、泌尿科、其他。心血管手术占据了流动止血钳市场的主导地位，因为大量复杂的手术需要有效的止血。根据美国疾病管制与预防中心 (CDC) 的数据，美国每年约有 805,000 例心臟病发作，导致心臟手术数量激增。在这些手术中，流动止血钳对于控制脆弱和难以触及的区域的出血至关重要，可以降低併发症的风险。外科医生更喜欢它们，因为它们能够在不规则表面和活动性出血部位进行手术。心臟病盛行率的不断上升、人口老化以及心臟搭桥手术和瓣膜置换等心臟手术的进步进一步刺激了需求。微创心血管介入的转变增加了快速有效的止血解决方案的使用，巩固了心血管外科手术作为主要应用领域的地位。

流动止血钳市场—地理洞察

受大量外科手术和先进的医疗保健基础设施的推动，北美占据了流动止血钳市场的大部分份额。根据美国疾病管制与预防中心 (CDC) 的数据，美国每年进行超过 5,000 万例手术，对有效止血解决方案的需求不断增加。该地区受益于 FDA 的频繁批准，这有助于引进创新的止血产品。心血管疾病和癌症等慢性疾病的日益流行，增加了手术的数量，进一步推动了市场的成长。此外，老年人口的增加使得他们更容易接受外科手术干预，这也增加了对先进止血剂的需求。强生、百特和美敦力等主要公司正大力投资研发以提高产品功效。门诊手术和微创手术的增加（尤其是在门诊手术中心）也刺激了需求。总体而言，强劲的医疗保健支出和技术进步使北美成为流动止血剂的关键市场。

由于外科手术量大和医疗设施先进，美国在流动止血钳市场占有相当大的份额。据美国疾病管制与预防中心称，美国每年进行超过 5,000 万例手术，对有效止血解决方案的需求不断增加。强生、百特和美敦力等主要参与者透过持续创新和新产品推出促进了市场成长。此外，人口老化日益加剧以及心血管疾病和癌症等慢性疾病的发生率不断上升，也推动了外科手术的介入。该国强大的监管框架以及 FDA 的频繁批准支持了先进止血产品的快速采用。医疗保健研究资金的增加和高额的医疗保健支出进一步推动了市场扩张。门诊和微创手术的增加，特别是在门诊手术中心，增加了对易于使用的止血钳的需求。此外，事故造成的创伤也导致紧急手术中流动止血钳的使用增加。总体而言，美国仍然是一个具有强劲成长潜力的关键市场。

流动止血钳市场-竞争格局：

流动止血钳市场竞争激烈，受技术进步、产品创新和主要参与者之间的策略合作的推动。本公司正专注于研发，推出疗效更高、应用更快、生物相容性更好的止血解决方案。 FDA 的频繁批准和新产品的推出正在促进市场扩张。合併、收购以及与医院和外科中心的合作是加强市场影响力的常见策略。强生公司（Ethicon）、百特国际（Floseal Hemostatic Matrix）、碧迪公司（BD）、美敦力和辉瑞等领导者凭藉广泛的止血解决方案占领了市场。此外，Stryker、Teleflex、CryoLife、CSL Behring、Hemostasis、LLC 和 Tissuemed Ltd 等公司也在透过持续创新扩大其产品组合。对微创手术技术的投资以及与医疗保健提供者的合作进一步塑造了竞争格局。激烈的竞争推动了产品性能、安全性和可访问性的提高，确保了市场持续成长。

最新动态：

2023 年 4 月，百特国际公司在 2023 年围手术期註册护理师协会 (AORN) 全球外科会议暨博览会上推出了其外科产品组合中的多项新产品，包括推出 Floseal + Recothrom 流动止血钳。这有助于公司扩大其产品种类并增加其产品的覆盖范围。

目录

第一章：流动止血钳市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 流动止血钳市场片段（依产品类型）
    • 流动止血钳市场片段（依应用）
    • 流动止血钳市场片段（依最终用户）
    • 流动止血钳市场（按国家/地区）
    • 流动止血钳市场（按地区）
  • 竞争洞察

第三章：流动止血钳的主要市场趋势

  • 流动止血钳市场驱动因素
    • 市场驱动因素的影响分析
  • 流动止血钳市场限制
    • 市场限制的影响分析
  • 流动止血钳的市场机会
  • 流动止血钳市场未来趋势

第四章：流动止血钳产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：流动止血钳市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：流动止血钳市场格局

  • 2024年流动止血钳市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：流动止血钳市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 明胶基止血剂
    • 胶原蛋白止血剂
    • 组合止血钳
    • 凝血酶止血剂

第 8 章：流动止血钳市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 心血管外科
    • 骨科手术
    • 一般外科
    • 神经外科
    • 妇科手术
    • 泌尿科
    • 其他

第九章：流动止血钳市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 门诊手术中心（ASC）
    • 专科诊所
    • 创伤中心

第 10 章：流动止血钳市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美流动止血钳主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲流动止血钳主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区流动止血钳主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲流动止血钳主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的流动止血钳主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：关键供应商分析-流动止血钳产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Johnson & Johnson Services, Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company (BD)
    • Pfizer Inc.
    • Medtronic plc
    • Teleflex Incorporated
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • CSL Behring LLC
    • CryoLife, Inc.
    • Ethicon, Inc.
    • Mallinckrodt Pharmaceuticals
    • Z-Medica, LLC
    • Hemostasis, LLC
    • Tissuemed Ltd
    • Biocer Entwicklungs-GmbH

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4926

REPORT HIGHLIGHT

Flowable Hemostats Market size was valued at US$ 750.54 Million in 2024, expanding at a CAGR of 6.01% from 2025 to 2032.

The Flowable Hemostats Market focuses on products used to control bleeding during surgical procedures. Flowable hemostats are thick, gelatinous substances that combine a hemostatic agent with a carrier material, making them easy to apply to irregular wound surfaces. These hemostats work by accelerating the body's natural clotting process, helping to manage bleeding quickly and effectively. They are widely used in surgeries such as cardiovascular, orthopedic, and general procedures. The market is driven by the rising number of surgical procedures globally, an aging population, and increasing trauma cases.

Advancements in hemostatic technology, such as faster application and improved biocompatibility, are enhancing their effectiveness. Additionally, the demand for minimally invasive surgeries has boosted the use of flowable hemostats. North America and Europe currently lead the market due to advanced healthcare systems, while Asia-Pacific is experiencing rapid growth. Challenges include high costs and regulatory hurdles. However, increasing healthcare investments and innovations continue to drive market expansion.

Flowable Hemostats Market- Market Dynamics

Rising surgical procedures globally increasing demand for hemostatic solutions.

The increasing number of surgical procedures worldwide is a significant driver for the flowable hemostats market. A study published in The Lancet estimated that approximately 234 million major surgical procedures are performed globally each year. This high volume underscores the critical need for effective hemostatic agents to manage bleeding during surgeries.

Flowable hemostats, known for their ease of application and efficacy in controlling bleeding, are becoming essential tools in the surgical toolkit. As the global population ages and the prevalence of chronic diseases rises, the demand for surgical interventions is expected to increase, further propelling the need for advanced hemostatic solutions.

Flowable Hemostats Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2025-2032)

Based on product type segmentation, Gelatin-based hemostats was predicted to show maximum market share in the year 2024

Based on application segmentation, Cardiovascular surgery was the leading application in 2024

Based on End-user segmentation, Hospitals was the leading end-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Flowable Hemostats Market- Segmentation Analysis:

The Global Flowable Hemostats Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into Four categories based on product type: Gelatin-based Hemostats, Collagen-based Hemostats, Combination Hemostats, and Thrombin-based Hemostats. Gelatin-based hemostats dominate the flowable hemostats market due to their versatility, effectiveness, and ease of use in controlling bleeding during various surgical procedures. These hemostats work by absorbing blood rapidly and creating a mechanical barrier to promote clotting. Their widespread use in cardiovascular, orthopedic, and general surgeries drives their market leadership. According to the U.S. Food and Drug Administration (FDA), gelatin-based hemostats are among the most commonly approved and utilized hemostatic agents in operating rooms. Surgeons prefer them for their biocompatibility, ease of application, and effectiveness on irregular wound surfaces. Additionally, the rising number of minimally invasive surgeries and trauma cases has further fueled their demand. Continuous advancements, such as improved formulations and faster absorption rates, are enhancing their performance, solidifying their position as the market leader.

The market is divided into two categories based on application: Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Gynecological Surgery, Urology Surgery, Other. Cardiovascular surgery dominates the flowable hemostats market due to the high volume of complex procedures requiring effective bleeding control. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attacks occur annually in the U.S., driving a surge in cardiac surgeries. Flowable hemostats are crucial in these surgeries to manage bleeding in delicate and hard-to-reach areas, reducing the risk of complications. Surgeons prefer them for their ability to work on irregular surfaces and in active bleeding sites. The increasing prevalence of heart diseases, aging populations, and advancements in cardiac procedures, such as bypass surgeries and valve replacements, further boost demand. The shift towards minimally invasive cardiovascular interventions has increased the use of quick and efficient hemostatic solutions, solidifying cardiovascular surgery as the leading application segment.

Flowable Hemostats Market- Geographical Insights

North America holds a major share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), over 50 million surgical procedures are performed annually in the U.S., increasing the demand for effective hemostatic solutions. The region benefits from frequent FDA approvals, which facilitate the introduction of innovative hemostatic products. The growing prevalence of chronic diseases, such as cardiovascular disorders and cancer, has increased the number of surgeries, further driving market growth. Additionally, a rising elderly population, which is more susceptible to surgical interventions, contributes to the demand for advanced hemostats. Major players like Johnson & Johnson, Baxter, and Medtronic are heavily investing in research and development to enhance product efficacy. The increase in outpatient procedures and minimally invasive surgeries, especially in ambulatory surgical centers, has also fueled demand. Overall, strong healthcare spending and technological advancements make North America a key market for flowable hemostats.

The United States holds a significant share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare facilities. According to the CDC, over 50 million surgeries are performed annually in the U.S., increasing the demand for effective bleeding control solutions. The presence of major players such as Johnson & Johnson, Baxter, and Medtronic contributes to market growth through continuous innovation and new product launches. Additionally, a growing aging population and rising prevalence of chronic diseases, such as cardiovascular disorders and cancer, are driving surgical interventions. The country's strong regulatory framework, with frequent FDA approvals, supports the rapid adoption of advanced hemostatic products. Increased funding for healthcare research and high healthcare expenditure further fuel market expansion. The rise in outpatient and minimally invasive surgeries, particularly in ambulatory surgical centers, has boosted demand for easy-to-use hemostats. Additionally, trauma cases from accidents contribute to increased usage of flowable hemostats in emergency procedures. Overall, the U.S. remains a key market with strong growth potential.

Flowable Hemostats Market- Competitive Landscape:

The flowable hemostats market is highly competitive, driven by technological advancements, product innovations, and strategic collaborations among key players. Companies are focusing on research and development to introduce hemostatic solutions with improved efficacy, faster application, and better biocompatibility. Frequent FDA approvals and new product launches are enhancing market expansion. Mergers, acquisitions, and partnerships with hospitals and surgical centers are common strategies to strengthen market presence. Leading players such as Johnson & Johnson (Ethicon), Baxter International (Floseal Hemostatic Matrix), Becton, Dickinson and Company (BD), Medtronic, and Pfizer dominate the market with a broad range of hemostatic solutions. Additionally, companies like Stryker, Teleflex, CryoLife, CSL Behring, Hemostasis, LLC, and Tissuemed Ltd are expanding their portfolios through continuous innovation. The competitive landscape is further shaped by investments in minimally invasive surgical technologies and collaborations with healthcare providers. This intense competition is driving improvements in product performance, safety, and accessibility, ensuring sustained market growth.

Recent Developments:

In April 2023, Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, including the launch of Floseal + Recothrom flowable hemostat. This helped the company to expand its product offerings and increase the reach of its product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLOWABLE HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Pfizer Inc.
  • Medtronic plc
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • CSL Behring LLC
  • CryoLife, Inc.
  • Ethicon, Inc.
  • Mallinckrodt Pharmaceuticals
  • Z-Medica, LLC
  • Hemostasis, LLC
  • Tissuemed Ltd
  • Biocer Entwicklungs-GmbH

GLOBAL FLOWABLE HEMOSTATS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Combination Hemostats
  • Thrombin-based Hemostats

GLOBAL FLOWABLE HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Surgery
  • Orthopedic Surgery
  • General Surgery
  • Neurosurgery
  • Gynecological Surgery
  • Urology Surgery
  • Other

GLOBAL FLOWABLE HEMOSTATS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Trauma Centers

GLOBAL FLOWABLE HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Flowable Hemostats Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Flowable Hemostats Market Snippet by Product Type
    • 2.1.2. Flowable Hemostats Market Snippet by Application
    • 2.1.3. Flowable Hemostats Market Snippet by End-user
    • 2.1.4. Flowable Hemostats Market Snippet by Country
    • 2.1.5. Flowable Hemostats Market Snippet by Region
  • 2.2. Competitive Insights

3. Flowable Hemostats Key Market Trends

  • 3.1. Flowable Hemostats Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Flowable Hemostats Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Flowable Hemostats Market Opportunities
  • 3.4. Flowable Hemostats Market Future Trends

4. Flowable Hemostats Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Flowable Hemostats Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Flowable Hemostats Market Landscape

  • 6.1. Flowable Hemostats Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Flowable Hemostats Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Gelatin-based Hemostats
    • 7.1.3. Collagen-based Hemostats
    • 7.1.4. Combination Hemostats
    • 7.1.5. Thrombin-based Hemostats

8. Flowable Hemostats Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular Surgery
    • 8.1.3. Orthopedic Surgery
    • 8.1.4. General Surgery
    • 8.1.5. Neurosurgery
    • 8.1.6. Gynecological Surgery
    • 8.1.7. Urology Surgery
    • 8.1.8. Other

9. Flowable Hemostats Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics
    • 9.1.5. Trauma Centers

10. Flowable Hemostats Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Flowable Hemostats Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Flowable Hemostats Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Flowable Hemostats Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Flowable Hemostats Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Flowable Hemostats Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Flowable Hemostats Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Baxter International Inc.
    • 11.2.3. Becton, Dickinson and Company (BD)
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Medtronic plc
    • 11.2.6. Teleflex Incorporated
    • 11.2.7. Integra LifeSciences Holdings Corporation
    • 11.2.8. Stryker Corporation
    • 11.2.9. CSL Behring LLC
    • 11.2.10. CryoLife, Inc.
    • 11.2.11. Ethicon, Inc.
    • 11.2.12. Mallinckrodt Pharmaceuticals
    • 11.2.13. Z-Medica, LLC
    • 11.2.14. Hemostasis, LLC
    • 11.2.15. Tissuemed Ltd
    • 11.2.16. Biocer Entwicklungs-GmbH

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us